Adenovirus-Specific Cytotoxic T-Lymphocytes for Refractory Adenovirus Infection
Phase 2
20
about 9.2 years
0.0833333333333333–79
10 sites in CA, CO, IN +5
What this study is about
This trial is testing a treatment with adenovirus-specific cytotoxic T cells in children, adolescents, and young adults who have a severe adenovirus infection that hasn't responded to other treatments. The treatment will be given after a stem cell transplant for primary immune deficiency disorders or solid organ transplants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take cytotoxic t-lymphocytes
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]